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Introduction
Genetic testing for high-penetrance BRCA1/2 mutations is usually available to individuals from high-risk families fulfilling stringent family-history (FH) criteria following geneticcounselling in specialized cancer genetic clinics. Recent studies show that a significant proportion of BRCA1/2 carriers lack a strong FH of cancer but can be identified through population-based approaches, not standard clinical care. [1, 2, 3] The GCaPPS (GeneticCancer-Prediction through Population-Screening) randomised controlled trial (RCT) compared population screening (PS) with FH-based testing for BRCA1/2 mutations in Ashkenazi Jewish (AJ) individuals (ISRCTN73338115). We found that PS for BRCA1/2 mutations in AJ population does not harm quality-of-life/psychological well-being [3] and is extremely cost-effective leading to 33days gain in life-expectancy and incremental costeffectiveness ratio(ICER)='-£2079/quality-adjusted-life-year(QALY)' well below the £20,000/QALY NICE threshold. [4] Pre-test genetic counselling is a fundamental element of international guidelines [5] for informed decision making prior to genetic testing. A range of decision-aids varying from pamphlets, booklets, computer-based programmes, audiotapes, to web-based platforms have been used as adjuncts to counselling to facilitate decision making in high-risk populations. Decision-aids reduce decisional conflict and lead to an increase in knowledge, accuracy of perceived benefits/harms, participation in decision making process and ability to make informed value-based choices. [6, 7] In addition group-based and telephone counselling approaches have been found to be beneficial and non-inferior in high-risk women. [8, 9, 10, 11, 12] For large-scale, population-based genetic testing to become feasible and practical it is necessary to move away from the 'traditional face-to-face genetic counselling' (TC) [13, 14] approach, which is cost intensive requiring significant health professional time. At present there is no established model for providing pre-test genetic counselling for genetic-testing on a population basis. [15] We hypothesised that using a DVD (audio-visual tool) could significantly reduce the duration and increase cost-efficiency compared with traditional faceto-face counselling, while being non-inferior in terms of knowledge gained, counselling satisfaction, risk perception and equivalent in uptake of genetic testing. We report on outcomes from the only RCT that we are aware of comparing TC and DVD-based genetic counselling (DVD-C) approaches in an unselected population-based setting, undertaken during recruitment to the GCaPPS study.
Methodology
Cluster randomised non-inferiority trial set within GCaPPS (ISRCTN73338115). Inclusion criteria: (a)individuals >18years, (b)AJ ethnicity Exclusion criteria: (a)known BRCA1/2 mutation, (b)previous BRCA1/2 testing, (c)first-degree relative(FDR) of a BRCA1/2 carrier.
All volunteers received non-directive pre-test genetic-counselling regarding genetic-testing for AJ BRCA1/2 founder-mutations. Genetic counselling was undertaken by a qualified genetic-counsellor with clinical/counselling supervision provided by a Regional Genetics Centre and a clinical-fellow experienced in cancer-genetics risk-assessment and management. It was structured to meet the goals of genetic counselling, [16, 17, 18] covering: interpretation of FH, knowledge about risk, inheritance, management options, advantages, disadvantages and psychosocial implications to promote informed choice and adaptation.
Recruitment clinics (clusters) were randomised to TC and DVD-C approaches.
Randomisation of clinics was essential for logistic, organisational and pragmatic reasons.
There was an initial DVD development process from Nov-2008 to Jan-2009. This study reports on genetic-counselling outcomes of clinics randomised from Feb-2009 until end of recruitment (July-2010) using the final DVD version. Randomisation was undertaken by a computer generated random number algorithm. Participants were blinded to the type of genetic-counselling when making an appointment. Appointments were made and randomisation implemented by the study administrator independent of the counsellors. DVD-C approach involved a DVD presentation (in the recruitment clinic) to small groups of volunteers (2-5) at a time. DVD-C volunteers subsequently saw a genetic counsellor for an individual genetic-counselling session (post-DVD) at the same appointment. Participants in the TC-group underwent face-to-face genetic-counselling only. FH and baseline questionnaires were collected prior to the DVD presentation (DVD-C) or prior to seeing the genetic counsellor (TC-group). Time taken for genetic-counselling was documented. Postcounselling questionnaires were filled and collected after the genetic-counselling session.
Individuals deciding to undergo BRCA1/2 genetic-testing were consented after geneticcounselling.
Outcomes: included uptake of genetic testing, change in cancer risk perception, increase in knowledge, counselling time and counselling satisfaction.
Secondary outcomes: relevance, satisfaction, adequacy, emotional impact and improvement of understanding with the DVD; and cost-minimisation analysis.
A baseline questionnaire assessed FH and socio-demographic characteristics. Knowledge was assessed by a specially developed 10-item (True=1/False=0) questionnaire (supplementary table-S1) at baseline and post genetic-counselling. Satisfaction with geneticcounselling was assessed post-counselling by the validated 6-item Genetic-CounsellingSatisfaction-Scale (GCSS): 5-point likert-scale (strongly-disagree=1, strongly-agree=5) for each item, maximum score=30. [19, 20] Cancer risk perception was measured on a previously used 0-100 scale at baseline and post-counselling. Baseline characteristics were calculated using descriptive statistics. Chi-square tests compared categorical variables and t-Test(parametric) and Mann-Whitney(non-parametric) tests compared continuous outcome variables between two independent samples.
Random-effects models that included a random intercept term for each cluster (clinic) compared outcomes between TC and DVD-C groups, and were adjusted for potential confounders: FH (high/low-risk), age, gender, parity, income, education and marital status.
The total knowledge-score was calculated as a sum of True=1 and False=0 for all 10 questions. Sensitivity analysis for knowledge-scores was undertaken by (a)correcting final score to reflect proportion of valid questions answered and (b)assigning a score='0' for missing answers. As the GCSS-scores were highly skewed with a significant peak at 30, the transformation | − 30| was considered. The resulting data distribution was approximated by a zero-inflated negative binomial-regression model, adjusted with the same confounders. Per-protocol and intention-to-treat analysis were evaluated for outcomes of DVD-C and TC groups. A sensitivity analysis with multivariate imputation using chained equations (MICE) [22] for missing data was undertaken for all outcomes. MICE iteratively simulates from suitable univariate imputation models that are fully conditional on all selected predictor variables, until convergence is reached. 50 fully imputed datasets were created to generate valid estimates and standard errors, and produce correct statistical inference.
Non-inferiority analysis is needed to determine if DVD-C is not worse than the current standard (TC) by an acceptable amount. A one-sided 97.5%CI was used to determine noninferiority for cancer risk perception, increase in knowledge and counselling satisfaction.
Non-inferiority was established when the 97.5%CI did not cross the non-inferiority margin. A two-sided 95%CI was used to test equivalency of genetic testing uptake as the aim of genetic-counselling is informed decision making rather than to increase/decrease testing. A superiority analysis was undertaken for counselling time.
.
The non-inferiority margins were based on clinically meaningful changes where available or set at no more than 0.5S.D worse than that for TC from prior studies [19, 23] 
Patient / Community involvement
The study was preceded by an extensive broad based consultation / engagement with all sections of the Jewish community which lasted almost a year (Supplementary table-S5) . Table-1 ). The mean age of participants was 53.9(S.D15) years; 66.8% were women and 33.2% men. Our findings suggest a significant proportion of the AJ population are interested in BRCA1/2 testing and find it acceptable. Most(89%) of participants opted for genetic-testing following counselling. The uptake of testing rates and means(S.D) for knowledge, GCSS, counselling time and risk perception are given in Table- Table- 2). Sensitivity analysis following multiple imputation of missing data also showed similar results (Table-2 ).
RESULTS

Between
Baseline knowledge level was significantly associated with decreasing age, and increasing levels of income and education, but independent of FH, gender, marital status and having children( Table-3 ). Overall genetic-counselling led to a significant increase in knowledge scores(p<0.0005).
Responses (n=316) to the DVD-evaluation questionnaire are given in Table-4. 98% people were satisfied with the overall information, amount of information and DVD length. 13% felt certain parts required more detailed explanation. Only 2% felt some parts could be left out (supplementary table-S5). 95% would recommend the DVD to others and 85-89% indicated it improved their understanding of risks/benefits/implications and purpose of genetic-testing.
Emotionally, 77% felt reassured; 87%-95% felt no significant degree of worry/concern/upset; 11% felt somewhat worried/concerned, 3% somewhat upset, and 1.3% 'quite-a-lot' worried/concerned after watching the DVD. Table-5 summarises responses on parts making people feel worried/concerned/upset/reassured.
The total genetic-counselling cost-estimate=£7,786.65(£19/volunteer) for DVD-C and £17,306.68(£33/volunteer) for TC groups. The reduction in face-to-face health professional consultation time with the DVD translated into a total cost difference=£9,520.03. DVD-based counselling led to a cost-saving= £14/volunteer counselled. Although the cost minimisation of £14/volunteer may seem to be small in individual terms, when extrapolated across a whole population it actually amounts to quite a substantial saving for the health care system.
DISCUSSION
To the best of our knowledge this is the first RCT to report on systematic pre-test geneticcounselling in a low-risk population (unselected for FH) of men and women undergoing BRCA1/2 mutation testing. The finding that DVD-C is not inferior to TC with respect to increase in knowledge, risk perception or counselling satisfaction; equivalent in uptake of testing and more cost-efficient (cost-saving=£14/volunteer) is of great importance and suggests that DVD-C can be used as an effective and efficient alternative to traditional pretest genetic-counselling.
Group genetic-counselling is reported to reduce the duration of counselling in high-risk populations, [8] but this is the first report of using a DVD in this situation. DVD is an audiovisual tool with several advantages. It can be distributed/accessed by post, the web, GP surgeries, community centres or other high-street sources and watched by people prior to their genetics appointment. Unlike group/telephone counselling it does not require a health professional to deliver the educational material. Printed educational material is also effective in increasing knowledge and facilitating decision making. [26, 27] We did not directly compare a printed decision aid with a DVD in this study. Pre-test genetic counselling reduces distress, improves patients' risk perception [28] and currently remains part of international guidelines for genetic testing. [5] Although no pre-test genetic-counselling was undertaken in two single arm contemporaneous Canadian [2] and Israeli [29] population studies, post-test counselling was provided, and good satisfaction reported by participants with the testing process. Such an approach of 'no pre-test counselling' or only 'post-test counselling ' has not yet been directly compared to TC in a randomised trial.
For population-based testing to be feasible, newer models for providing information for informed decision making prior to genetic-testing are necessary, which need to be properly evaluated in well-designed trials and ideally compared to the gold-standard of TC. While we have demonstrated a viable DVD-based model, other models are also being explored/ developed. Telephone genetic-counselling has been successfully used for triaging women from high-risk families for TC [10] and disclosure of test result. [9, 30, 31] Three RCTs compared telephone counselling to TC in high-risk women attending genetics clinics, No difference in satisfaction [32] was reported in one. Two were non-inferiority trials and found telephone counselling was non-inferior to TC, [11, 12] though lower testing uptake was reported in one. [11] Telegenetics has been compared to TC in a RCT and reported to cost less with no difference in satisfaction though it was associated with 10% lower attendance. The strengths of this report include the cluster randomised design, non-inferiority analysis, community-based model for undergoing genetic-testing, and a high questionnaire response rate (73-100%). The differences in number of volunteers between the two study arms is explained by the randomisation of clinics (not volunteers), varying clinic times and differences in clinic sizes. But as expected, the baseline characteristics of the groups were in balance (table-1). Lack of qualitative data may be considered a weakness and restriction to AJ participants may limit generalizability to other populations. We were also unable to analyse long term outcomes post-disclosure of the test result and this may be a limitation of the analysis. We did not include the 15 minute patient time taken to watch the DVD in the cost-minimisation analysis because our analysis covers a health care perspective in line with NICE methods guidance and therefore as per NICE guidance patient costs are excluded.
Besides, in practice we would expect patients to have watched the DVD before attending for a genetic counselling session. We guaranteed compliance and maximised questionnaire response by making people watch the DVD prior to counselling. Hence, in the future, when the DVD is delivered at home, it it is important to ensure that people do watch the DVD at home prior to attending the genetic counselling session to ensure generalisability of results.
The high genetic-testing uptake rate found in our study has also been reported by others. [2, 36, 37] This may also be a function of a self-selected population, and/or non-directive informative pre-test counselling received by participants. Our knowledge questionnaire was able to detect changes in knowledge (sensitivity-to-change). The increase in knowledge following pre-test counselling found in a low-risk population is similar to previous reports from high-risk populations. [26, 38, 39] Older studies reported lower levels of knowledge about genetic-testing and understanding of cancer risk. [26, 39] However, our relatively higher mean baseline-score (>7) suggests that the average person coming forward for BRCA1/2 testing today may have greater levels of awareness/knowledge which is reassuring. The lack of difference in knowledge scores between those with and without a strong FH of cancer re-emphasises this point and is contrary to previous findings of an association between knowledge and FH of cancer. [38] The high baseline levels of knowledge may be a reflection of number of factors such as (a) self-selected trial participants, (b) the higher education and income levels known to be prevalent in the UK Jewish community compared to the rest of the non-Jewish general population, and (c) ever increasing public information and awareness on this issue. Our finding that level of knowledge is associated with education and income is consistent with earlier reports, [38, 40] and with the positive correlation (Spearman's-rho=0.3, p<0.005) between income and education levels, expected in a general population. Younger people had greater knowledge about genetic-testing than older people. To the best of our knowledge this has not been reported before. Factors that could have contributed to this include greater awareness of genetics, its recent incorporation into school curriculums, proactive behaviour and better access to sources of information in younger age groups.
Decision making where each option has benefits/risks that people may value differently can be a difficult process. Overall our DVD was well received with high satisfaction levels, and enabled people to make specific, deliberated choices appropriate for them. The increase in knowledge is consistent with the effectiveness of the DVD in providing relevant information, and improving the understanding of purpose/benefits/risks/implications related to genetictesting. Getting the right balance between DVD-length and amount of information provided is challenging. The 98% satisfaction with length/information, 88% feeling no need for further explanation and 95% willingness to recommend it suggests our 15minute DVD struck the right balance for most people. A longer/more detailed DVD would yield small improvements, while greatly increasing the proportion of disaffected people. Need for more information on insurance/risks/inheritance highlighted by a small proportion represent areas for further development. The DVD quality can also be improved by incorporating qualitative data and using better production, film making and editing facilities.
The ability to identify 50% additional carriers, lack of psychological harm and costeffectiveness of population testing for BRCA1/2 mutations in AJ individuals [3, 4, 29] [43, 44, 45] and availability of panel testing will lead to an ever increasing demand for genetic services with newer challenges for pre-test education and genetic-counselling. Future research needs to compare telegenetics, telephone counselling, use of dial-in/web-based helplines, web apps along with DVD/other decision tools to identify/develop cost-efficient mass-based strategies to optimise education and facilitate informed decision making without negatively affecting satisfaction, knowledge, or psychological well-being in the general non-AJ population. A move away from TC is necessary to achieve the full benefit of genomic advances to deliver predictive, preventive, personalized, and participatory(P4) medicine for cancer prevention.
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Satisfaction and Risk perception
This figure shows outcomes and non-inferiority margins for difference between DVD-based counselling (DVD-C) and traditional face-to-face genetic counselling (TC) groups for increase in knowledge (Fig 2a) , counselling satisfaction (Fig 2b) and cancer risk perception (Fig 2c) . Random-effects models adjusted for covariates of FH (high/low risk), age, gender, parity, income, education and marital status were used to compare outcomes between TC and DVD-C groups. A one-sided 97.5%CI was used to determine non-inferiority for increase in knowledge (Fig 2a) , counselling satisfaction (Fig 2b) and cancer risk perception (Fig 2c) .
The x-axis shows the adjusted mean difference (DVD-C -TC) and 97.5% Confidence Limit.
Non-inferiority is established when the 97.5% CI (red line in the figure) does not cross the non-inferiority margin (black line in the figure). 
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